Sign in
4

Changes in Ownership

Compass Therapeutics, Inc. Filed Acc 0001171843-26-000051

General Counsel acquired 150,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Anderman Jonathan General Counsel 2026-01-02 Grant or award +150,000 $5.17 $775,500 171,000 D
Derivatives
Anderman Jonathan General Counsel 2026-01-02 Grant or award · Stock Option (Right to Buy) +720,000 720,000 D
Loading xslF345X05/ownership.xml…